Defining and Managing Treatment-Resistant Depression: Efficacy and Real-World Insights

A panel of mood disorder experts explore the challenges of treatment-resistant depression (TRD), including defining TRD, managing partial improvement, and addressing adverse reactions. They discuss the role of glutamate in TRD, efficacy and safety considerations from clinical trials, treatment half-life, and real-world experiences with pharmacovigilance.

EP: 1.Expert Insights into Navigating MDD Prevalence, Stigma, and Treatment Challenges for Improved Patient Outcomes

EP: 2.Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics

EP: 3.Commentary on Redefining Depression Management with Updated Treatment Strategies

EP: 4.Navigating Non-Response: A Holistic Approach to Patient Care

EP: 5.Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

EP: 6.Quantifying Success: Measuring Depth of Treatment Response in MDD

EP: 7.Access Challenges: Bridging Insurance Gaps for MDD Innovations

EP: 8.Depression Treatment: Expert Guide to Medication Management & Therapeutic Success

EP: 9.From Neuroplasticity to Patient Conversations: Managing Affective Disorders Effectively

EP: 10.Managing Persistent MDD: Case Studies and Treatment Challenges

EP: 11.Evaluating Treatment Failure and Symptomatic Remission in MDD

EP: 12.Exploring Rapid-Acting Therapies in MDD: Pharmacodynamics and Treatment Evolution

EP: 13.Addressing Unsatisfactory Responses in Chronic MDD

Now Viewing